Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€74.55
18:17
€60.00
07.05.22
-0.07%

Higher EBIT margin than peer group
Probably not worthwhile Investment
Low dividend yield expected
Below average Management
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€74.55
18:17
€60.00
07.05.22
-0.07%

Higher EBIT margin than peer group
Probably not worthwhile Investment
Low dividend yield expected
Below average Management
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€1.91
06.05.21
€1.30
06.05.22
-1.89%

Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€81.20
03.05.21
€75.00
03.05.22
-1.66%

Could be worthwhile Investment >10% per year
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€81.20
03.05.21
€75.00
03.05.22
-1.66%

Could be worthwhile Investment >10% per year
buy
Flexion Therapeutics Inc.

Start price
Target price
Perf. (%)
€6.50
03.05.21
€8.00
03.05.22
-6.92%

Could be worthwhile Investment >10% per year
buy
Ziopharm Oncology

Start price
Target price
Perf. (%)
€2.72
03.05.21
€5.00
03.05.22
-12.50%

Could be worthwhile Investment >10% per year
buy
Kezar Life Sciences

Start price
Target price
Perf. (%)
€4.72
03.05.21
€6.00
03.05.22
-9.75%

Could be worthwhile Investment >10% per year
buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€7.90
03.05.21
€10.00
03.05.22
-8.29%

Could be very worthwhile Investment >20% year
buy
Aptose Biosciences

Start price
Target price
Perf. (%)
€4.64
01.05.21
€4.50
01.05.22
-11.21%

Could be worthwhile Investment >10% per year
Virbac S.A.

Start price
Target price
Perf. (%)
€275.00
28.04.21
€270.00
28.04.22
-3.09%

Could be worthwhile Investment >10% per year
buy
Daiichi Sankyo Co Ltd

Start price
Target price
Perf. (%)
€22.68
26.04.21
€25.00
26.04.22
-7.19%

Could be worthwhile Investment >10% per year
buy
Daiichi Sankyo Co Ltd

Start price
Target price
Perf. (%)
€22.68
26.04.21
€25.00
26.04.22
-7.19%

Could be worthwhile Investment >10% per year
buy
Daiichi Sankyo Co Ltd

Start price
Target price
Perf. (%)
€22.68
26.04.21
€25.00
26.04.22
-7.19%

Could be worthwhile Investment >10% per year
buy
Daiichi Sankyo Co Ltd

Start price
Target price
Perf. (%)
€22.68
26.04.21
€25.00
26.04.22
-7.19%

Could be worthwhile Investment >10% per year
buy
Daiichi Sankyo Co Ltd

Start price
Target price
Perf. (%)
€22.68
26.04.21
€25.00
26.04.22
-7.19%

Could be worthwhile Investment >10% per year
buy
Daiichi Sankyo Co Ltd

Start price
Target price
Perf. (%)
€22.68
26.04.21
€25.00
26.04.22
-7.19%

Could be worthwhile Investment >10% per year
buy
Rigel Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€3.03
23.04.21
€3.50
23.04.22
-9.64%

Could be worthwhile Investment >10% per year
Boiron S.A.

Start price
Target price
Perf. (%)
€38.55
13.04.21
€36.00
13.04.22
-0.52%

Could be worthwhile Investment >10% per year
buy
Stratec SE

Start price
Target price
Perf. (%)
€116.60
03.03.21
€165.00
03.03.22
-1.37%

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
positive Cash Flow expected
High valuation
buy
Inovio Pharma

Start price
Target price
Perf. (%)
€11.30
20.02.21
€6.00
20.02.22
-51.32%

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
EBIT decline/stagnation expected
Novan Inc

Start price
Target price
Perf. (%)
€1.68
18.02.21
€3.00
17.08.21
-42.71%

Could be very worthwhile Investment >20% year
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€82.00
02.02.21
€90.00
02.02.22
-22.02%

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Some uniques
Innovative
buy
Zosano Pharma

Start price
Target price
Perf. (%)
€0.90
23.01.21
-
23.01.22
-21.73%

Could be very worthwhile Investment >20% year
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.86
23.01.21
€3.00
23.01.22
-12.59%

Could be very worthwhile Investment >20% year
Higher risks for its business